| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444359 | European Journal of Cancer | 2013 | 8 Pages |
Abstract
This study confirmed that KRAS testing is definitely part of the management of most of mCRC patients, despite discrepancies observed in the rate of prescription and the time of results.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
A. Lièvre, P. Artru, M. Guiu, P. Laurent-Puig, J.L. Merlin, J.C. Sabourin, J. Viguier, A. Bastie, A. Seronde, M. Ducreux,